Total Voting Rights

Summary by AI ^BETAClose X

CVS Group plc has announced the issuance of 510 new ordinary shares following the exercise of options under its SAYE Plans, bringing the total issued share capital to 70,156,603 ordinary shares, each with one voting right. The company holds no treasury shares, resulting in a total of 70,156,603 voting rights, which shareholders should use as the denominator for notification calculations under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

CVS Group plc

27 February 2026

CVS Group plc

("CVS" or the "Company")

Total Voting Rights

CVS, the UK's listed veterinary group and a leading provider of veterinary services, confirms that certain employees have exercised options under the CVS Group 2023 SAYE Plan (2023-2026) and 2024 SAYE Plan (2024/2027) totalling 510 ordinary shares of 0.2 pence each ("Ordinary Shares").

The sum of 510 new Ordinary Shares were issued to satisfy the balance of Ordinary Shares arising from the SAYE Exercise. Admission of the 510 new Ordinary Shares has been satisfied by the Company's block listing admitted to the London Stock Exchange on 30 December 2021.

The Company has a total issued share capital of 70,156,603 Ordinary Shares, each carrying one voting right. The Company holds no Ordinary Shares in treasury and the total number of voting rights is therefore 70,156,603.

This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Contacts:

CVS Group plc via Camarco

Scott Morrison, General Counsel and Company Secretary

Camarco (Financial PR)

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

About CVS Group plc (www.cvsukltd.co.uk)

   CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on
   the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical
   services to its clients and their animals, with outstanding and dedicated clinical teams and support
   colleagues at the core of its strategy.

   The Group operates over 475 veterinary practices across its two territories, including specialist
   referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division,
   CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online
   retail business ("Animed Direct").

The Group employs 9,000 personnel, including 2,500 veterinary surgeons and 3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END